Advanced Biomed Inc. key statistics and ratios

In fiscal 2026, Advanced Biomed Inc. had return on equity of 54.4%, an operating margin of -4883.8%, debt equal to 0.0% of equity and a current ratio of 9.33. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Advanced Biomed Inc.: financial ratios, annual
Fiscal year	2026Jun 2026
Operating margin	<−999%
Net margin	>999%
Free-cash-flow margin	<−999%
Return on equity	54.4%
Return on assets	48.6%
Asset turnover	0.01
Current ratio	9.33
Debt to equity	0.0%
Capital spending as % of revenue	0.0%
Free cash flow ÷ net income	−29.2%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Advanced Biomed Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Advanced Biomed Inc.